Last updated: November 18, 2026
Key Takeaways
- Anthropic priced its IPO at $83.00 per share on November 18, 2026, according to the company's pricing announcement. Reuters reported the same figure that day.
- $83.00 is 6.4% above the $78 high end of the range and 12.2% above the $74 midpoint.
- The share count rose from 825,000,000 marketed to 980,000,000 sold, an 18.8% increase.
- The opening trade is set separately by the Nasdaq IPO Cross auction on the first trading day, scheduled for November 19, 2026.
What was the Anthropic IPO price?
The Anthropic IPO price was $83.00 per share. Anthropic, PBC announced on November 18, 2026 that it had priced 980,000,000 shares of Class A common stock at that level, with 956,351,354 shares sold by the company and 23,648,646 sold by existing stockholders. The marketed range had been $70 to $78.
Reuters reported the $83 figure the same day, citing a person familiar with the matter, and said the deal had been increased from the 825 million shares first planned. The company's announcement added a 30-day option for the underwriters to buy up to 147,000,000 more shares.
Multiply it out and the base deal is about $81.3 billion before underwriting discounts. What that price says about the company's total value is a separate question, taken up in the Anthropic valuation history.
How does bookbuilding set an IPO offer price?
Bookbuilding sets an IPO offer price by collecting investor orders before any shares trade. Underwriters publish a price range, meet investors on a roadshow, record how many shares each would buy at each price, and then recommend a final price. The company and its underwriters settle the figure, usually the evening before trading starts.
Anthropic's process followed that pattern. The roadshow launched on November 10, 2026 with a $70 to $78 range, led by Goldman Sachs & Co. LLC and Morgan Stanley, and pricing came eight days later. Reuters reported that demand reached several times the shares on offer.
The SEC's investor bulletin on IPOs describes the tension inside this negotiation plainly. A company wants a higher price so it raises more capital. Underwriters want the shares to sell well, which can pull toward a lower price. The final number is a negotiated result informed by the order book, not a formula. Anyone who wants to see the terms in their original form can find them in the Anthropic IPO prospectus.
Marketed range vs final price
Anthropic's final price landed $5.00 above the high end of its range, and the deal got bigger at the same time. Both changes point the same way: the book could absorb more stock at a higher price than the range assumed.
| Measure | Figure |
|---|---|
| Low end of marketed range | $70.00 |
| Midpoint of marketed range | $74.00 |
| High end of marketed range | $78.00 |
| Final offer price | $83.00 |
| Premium to the high end | 6.4% |
| Premium to the midpoint | 12.2% |
| Shares marketed | 825,000,000 |
| Shares sold | 980,000,000 (up 18.8%) |
One detail is easy to miss. The concurrent private placement described in the November 17, 2026 S-1/A was sized in dollars, $26.0 billion of Class N stock at the IPO price. A higher offer price therefore meant fewer shares for those buyers. At the $74 midpoint, the filing showed about 135.1 million shares for a $10.0 billion commitment. At $83.00 the same dollars buy roughly 120.5 million, by simple division.
Why is the offer price different from the opening trade?
The offer price and the opening trade differ because they are set by different people at different times. The offer price comes from the underwriters' order book the night before listing. The opening trade comes from an exchange auction on the first trading day, where anyone can enter buy and sell orders.
On Nasdaq that auction is the IPO Cross. Nasdaq's fact sheet describes a display-only period in which orders are collected and an indicative price is published, followed by a pre-launch period of no fixed length. When the lead underwriter signals it is ready, Nasdaq runs the cross, and the algorithm picks the single price that executes the most shares.
A hypothetical example with round numbers shows the logic. Assume an offer price of $50.
| Candidate price | Shares bid at or above | Shares offered at or below | Shares that can match |
|---|---|---|---|
| $55 | 20 million | 10 million | 10 million |
| $58 | 12 million | 16 million | 12 million |
| $61 | 6 million | 22 million | 6 million |
In this illustration the cross opens the stock at $58, because 12 million shares is the largest matched quantity. The $50 offer price played no part in the calculation. The same mechanism can just as easily produce an opening print below the offer price when sell interest is heavier. More on that session is in the guide to IPO first day trading.
What the offer price leaves out
The $83.00 figure answers one narrow question: what allocated investors paid. Several things a trader might assume from it are not in the number.
- Access. The S-1/A said up to 20% of offered shares could be allocated to retail investors through six named platforms, depending on demand. Everyone else transacts at market prices, as explained in can I buy Anthropic stock.
- What earlier holders paid. The filing's dilution table, built on the $74 midpoint, showed existing stockholders had paid an average of $11.50 per share.
- Price support. The filing names Morgan Stanley & Co. LLC as stabilization agent. The SEC bulletin warns that underwriter buying can support a new stock in its first days and that the price may fall once it stops.
- Future supply. Shares held by insiders become sellable in stages under the Anthropic lock-up period, starting on the first trading day.
None of this says where the stock goes. It says the offer price is a reference point, and the market price is a different thing.
Frequently Asked Questions
Was the Anthropic IPO priced above its range?
Yes. Anthropic marketed its IPO at $70 to $78 per share on November 10, 2026 and priced it at $83.00 on November 18, 2026. That is $5.00, or 6.4%, above the high end of the range. The number of shares sold also increased, from 825,000,000 to 980,000,000.
Can I buy Anthropic stock at the IPO price?
Only investors who received an allocation before pricing paid $83.00. The prospectus said retail investors could request shares through Charles Schwab, Fidelity, Robinhood, Trade-PMR, SoFi and E*TRADE, with no guarantee of a fill. After listing, ANT is bought at the prevailing market price, which can be higher or lower.
Who decides the IPO price?
The company and its underwriters set it together. For Anthropic, the lead underwriters were Goldman Sachs and Morgan Stanley. They gathered investor orders during the roadshow, and the price was set from that order book on November 18, 2026. The SEC reviews disclosure but does not set or approve the price.
What price did ANT open at?
As of November 18, 2026, ANT had not yet traded, so no opening price existed. The first trade was scheduled for November 19, 2026 through the Nasdaq IPO Cross, an auction that can open a stock above or below its offer price. Check a live quote or the exchange's record for the actual figure.
What is the difference between the IPO price and the market price?
The IPO price is a single negotiated number paid once by allocated investors. The market price changes continuously and is set by buyers and sellers on the exchange. For ANT, the IPO price is $83.00. The market price is whatever the most recent trade on Nasdaq shows at the moment you look.
Conclusion
The Anthropic IPO price is $83.00 per share, set on November 18, 2026 above a $70 to $78 range and on a larger deal than first marketed. Treat it as the price of one transaction between the company and allocated investors. For anything after the first trade, look at the live market price and the final prospectus on SEC EDGAR.
Related reading: the full Anthropic IPO overview and the Anthropic IPO timeline.
References
- Anthropic - Anthropic prices initial public offering (November 18, 2026)
- Reuters via MarketScreener - Anthropic prices blockbuster IPO at $83 a share, source says (November 18, 2026)
- SEC EDGAR - Anthropic, PBC Amendment No. 3 to Form S-1 (November 17, 2026)
- Nasdaq - Nasdaq IPO Cross fact sheet
- SEC Office of Investor Education and Advocacy - Updated Investor Bulletin: Investing in an IPO
Keep Reading
Disclaimer: This article is for educational and informational purposes only and is not investment, legal or tax advice, or a recommendation to buy or sell any security. Leveraged and inverse ETFs are complex products intended for short-term use by experienced traders, and investors can lose their entire investment. Read a fund's prospectus before investing. WOLF Financial is a digital marketing agency, not a registered investment adviser or broker-dealer.







